Relative Strength Chart Daiichi Sankyo Company, Limited

Equities

Market Closed - Japan Exchange Other stock markets 06:30:00 13/01/2026 GMT			5-day change	1st Jan Change
3,540.00 ^JPY	-0.06%		+0.28%	+5.73%

12:50pm	TROPION-Lung17 TROP2 Biomarker Directed Phase 3 Trial of DATROWAY Initiated in Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer	CI
01-12	Daiichi Sankyo Company, Limited Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 01:30 PM

End-of-day quotes

		Sector	Change	5d. change	Varia. Jan 1.	1-year change	5-years change	Capi.	ST	MT	LT
	DAIICHI SANKYO COMPANY, LIMITED	Other Pharmaceuticals	-0.06%	+0.28%	+5.73%	-14.84%	-2.75%	41.47B